OBJECTIVE: To determine how genetic factors might influence the progression of nonalcoholic fatty liver disease (NAFLD). DESIGN/INTERVENTION: Beginning in adolescence, male C57BL6 (BL6) and 129/SVJ mice were fed control (n=15/group) or high-fat (HF) diets (n=30/group) for 6 months. MAIN OUTCOME MEASURES: Assessed were body weight, insulin resistance, hepatic production of free radicals, expression of cytokines and fibrosis-related genes and severity of hepatic steatosis, injury and fibrosis. RESULTS: High-fat diets induced comparable obesity, hepatic steatosis and insulin resistance in the two strains. Compared with BL6 mice, 129/SVJ mice had impaired induction of antioxidant genes, generated three- to four-fold more free radicals and exhibited two-fold greater induction of profibrogenic cytokines (interleukin-4 and transforming growth factor-beta1) and fibrosis-related genes (fibronectin and tissue inhibitor of metalloproteinase-1) (all P<0.05 for 129 vs BL6). Surprisingly, however, induction of collagen I alpha1 mRNA and accumulation of Sirius red-stained fibrils and hepatic hydroxyproline were similar in BL6 and 129/SVJ mice, and although patchy sinusoidal fibrosis emerged in both strains, neither developed bridging fibrosis. CONCLUSIONS: Although BL6 and 129/SVJ mice with diet-induced obesity, insulin resistance and steatosis differed with respect to several factors that are thought to influence human NAFLD progression, they developed comparable liver fibrosis. Moreover, none of the risk factors for NAFLD-related cirrhosis in humans, including obesity, insulin resistance, chronic inflammatory and oxidant stress, steatohepatitis or activation of fibrogenic genes, proved to be sufficient to cause cirrhosis in these mice, even when exposure to one or more of these insults was very prolonged.
OBJECTIVE: To determine how genetic factors might influence the progression of nonalcoholic fatty liver disease (NAFLD). DESIGN/INTERVENTION: Beginning in adolescence, male C57BL6 (BL6) and 129/SVJ mice were fed control (n=15/group) or high-fat (HF) diets (n=30/group) for 6 months. MAIN OUTCOME MEASURES: Assessed were body weight, insulin resistance, hepatic production of free radicals, expression of cytokines and fibrosis-related genes and severity of hepatic steatosis, injury and fibrosis. RESULTS: High-fat diets induced comparable obesity, hepatic steatosis and insulin resistance in the two strains. Compared with BL6 mice, 129/SVJ mice had impaired induction of antioxidant genes, generated three- to four-fold more free radicals and exhibited two-fold greater induction of profibrogenic cytokines (interleukin-4 and transforming growth factor-beta1) and fibrosis-related genes (fibronectin and tissue inhibitor of metalloproteinase-1) (all P<0.05 for 129 vs BL6). Surprisingly, however, induction of collagen I alpha1 mRNA and accumulation of Sirius red-stained fibrils and hepatic hydroxyproline were similar in BL6 and 129/SVJ mice, and although patchy sinusoidal fibrosis emerged in both strains, neither developed bridging fibrosis. CONCLUSIONS: Although BL6 and 129/SVJ mice with diet-induced obesity, insulin resistance and steatosis differed with respect to several factors that are thought to influence human NAFLD progression, they developed comparable liver fibrosis. Moreover, none of the risk factors for NAFLD-related cirrhosis in humans, including obesity, insulin resistance, chronic inflammatory and oxidant stress, steatohepatitis or activation of fibrogenic genes, proved to be sufficient to cause cirrhosis in these mice, even when exposure to one or more of these insults was very prolonged.
Authors: Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo Journal: Gastroenterology Date: 2005-07 Impact factor: 22.682
Authors: David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal Journal: Hepatology Date: 2005-06 Impact factor: 17.425
Authors: Soumen K Manna; Andrew D Patterson; Qian Yang; Kristopher W Krausz; Jeffrey R Idle; Albert J Fornace; Frank J Gonzalez Journal: J Proteome Res Date: 2011-07-28 Impact factor: 4.466
Authors: Igor P Pogribny; Athena Starlard-Davenport; Volodymyr P Tryndyak; Tao Han; Sharon A Ross; Ivan Rusyn; Frederick A Beland Journal: Lab Invest Date: 2010-06-14 Impact factor: 5.662
Authors: Jamil A Haque; Ryan S McMahan; Jean S Campbell; Masami Shimizu-Albergine; Angela M Wilson; Dianne Botta; Theo K Bammler; Richard P Beyer; Thomas J Montine; Matthew M Yeh; Terrance J Kavanagh; Nelson Fausto Journal: Lab Invest Date: 2010-06-14 Impact factor: 5.662
Authors: Franziska Richter; Lauryn Gabby; Kimberly A McDowell; Caitlyn K Mulligan; Krystal De La Rosa; Pedrom C Sioshansi; Farzad Mortazavi; Ingrid Cely; Larry C Ackerson; Linda Tsan; Niall P Murphy; Nigel T Maidment; Marie-Françoise Chesselet Journal: Neurobiol Aging Date: 2016-12-01 Impact factor: 4.673
Authors: Yuwen Luo; Christine M Burrington; Emily C Graff; Jian Zhang; Robert L Judd; Promporn Suksaranjit; Quanhathai Kaewpoowat; Samantha K Davenport; Ann Marie O'Neill; Michael W Greene Journal: Am J Physiol Endocrinol Metab Date: 2015-12-15 Impact factor: 4.310
Authors: Vera H I Fengler; Tanja Macheiner; Sonja M Kessler; Beate Czepukojc; Katja Gemperlein; Rolf Müller; Alexandra K Kiemer; Christoph Magnes; Johannes Haybaeck; Carolin Lackner; Karine Sargsyan Journal: PLoS One Date: 2016-05-11 Impact factor: 3.240
Authors: Michael D Roberts; C Brooks Mobley; Ryan G Toedebush; Alexander J Heese; Conan Zhu; Anna E Krieger; Clayton L Cruthirds; Christopher M Lockwood; John C Hofheins; Charles E Wiedmeyer; Heather J Leidy; Frank W Booth; R Scott Rector Journal: BMC Gastroenterol Date: 2015-10-30 Impact factor: 3.067